Concepedia

Benjamin H. Lok

BH

39

Publications

2.3K

Citations

21

H-Index

2010

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Princess Margaret Cancer Centre

University of Toronto

New York University

University Health Network

Benjamin H. Lok is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2010–2025

39

Publications

39

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Eric E. Gardner, Benjamin H. Lok, Valentina E. Schneeberger et al. · Cancer Cell · 2017 · 513 citations · Full text

, , +9

PARP Inhibitor Activity Correlates with <i>SLFN11</i> Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger et al. · Clinical Cancer Research · 2016 · 326 citations · Full text

RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination

Benjamin H. Lok, Alison C. Carley, B Tchang et al. · Oncogene · 2012 · 205 citations · Full text

, , +7

Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity

Joel D. Pearson, Katherine Huang, Marek Pacal et al. · Cancer Cell · 2021 · 166 citations · Full text

, , +9

Target engagement imaging of PARP inhibitors in small-cell lung cancer

Brandon Carney, Susanne Kossatz, Benjamin H. Lok et al. · Nature Communications · 2018 · 106 citations · Full text

Rows per page

1–5 of 39